CareLit Fachartikel

Immunomodulating drugs in multiple sclerosis: compliance, satisfaction and adverse effects evaluation in a German MS-population

S Twork, I Nippert, P Scherer, J Haas, D Pöhlau, J Kugler · Aktuelle Neurologie · 2007 · Heft 09

Dokument
1137156
CareLit-ID
Jahr
2007
Publikation
PDF
nein
Metadaten
DOI
ja
zitierfähig

Bibliografische Angaben

Zeitschrift
Aktuelle Neurologie
Autor:innen
S Twork, I Nippert, P Scherer, J Haas, D Pöhlau, J Kugler
Ausgabe
Heft 09 / 2007
Seiten
–
Erschienen: 2007-09-11 00:00:00
ISSN
0302-4350
DOI
10.1055/s-2007-987758

Zusammenfassung

Objective: Assessment of compliance, satisfaction and adverse effects in a German multiple sclerosis (MS) population treated with immunomodulating drugs. Methods: A standardised, anonymous questionnaire was sent to 1985 members with MS of the Berlin section of the German Multiple Sclerosis Association. Patients were questioned in regards to sociodemographic data, MS related topics, therapy, adverse effects and compliance. The response rate was 51.1%, from which 681 patients experienced in therapy with beta-Interferon 1a or 1b or Glatirameracetate were selected. Results: Most participants were treated with beta-I…

Schlagworte

Compliance Population Association Depression Berlin Aktuelle Neurologie